1 follower
Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Their goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. They will adva... Read more
Dominik Schumacher
Isotopen Technologien München
1 follower
Cellphire Therapeutics
3 followers
Entos
1 follower
Thermo Fisher Scientific
166 followers
Regeneron
94 followers
Agilent Technologies
63 followers
Zafrens
1 follower
Upvest
2 followers
Merck Group
32 followers
Alexion Pharmaceuticals
34 followers
BioNTech
13 followers
Explore companies